Literature DB >> 1339450

Rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Properties of phospho- and dephospho- forms and of two mutants in which Ser32 has been changed by site-directed mutagenesis.

I J Kurland1, M R el-Maghrabi, J J Correia, S J Pilkis.   

Abstract

The mechanism by which cAMP-dependent protein kinase-catalyzed phosphorylation modulates the activities of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase was examined after site-specific mutation of the cAMP-dependent phosphorylation site (Ser32) to aspartic acid or alanine. The mutant and wild-type enzymes were overexpressed in Escherichia coli in a rich medium to levels as high as 30 mg/liter and were then purified to homogeneity. The kinetic properties of the Ser32-Ala mutant were identical with the dephosphorylated wild-type bifunctional enzyme. Mutation of Ser32 to aspartic acid mimicked several effects of cAMP-dependent phosphorylation: there was an increase in the Km for fructose 6-phosphate for 6-phosphofructo-2-kinase and an increase in the maximal velocity of fructose-2,6-bisphosphatase. Fructose-2,6-bisphosphatase activity of the Ser32-Asp mutant was 75% that of the phosphorylated wild-type enzyme, the mutant's kinase reaction had an identical dependence on fructose 6-phosphate, while its maximum velocity was only 60% that of the phosphorylated wild-type enzyme over a wide pH range. Furthermore, catalytic subunit-catalyzed in vitro phosphorylation of the Ser32-Ala mutant on Ser33 increased the Km for fructose 6-phosphate by 4-fold for the 6-phosphofructo-2-kinase. The results support the hypothesis that Ser32 is an important residue in the regulation of the activities of the bifunctional enzyme and that phosphorylation of Ser32 can be functionally substituted by aspartic acid. The results suggest a role for negative charge in the effect of phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339450

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Authors:  Mark H Rider; Luc Bertrand; Didier Vertommen; Paul A Michels; Guy G Rousseau; Louis Hue
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  zif-1 translational repression defines a second, mutually exclusive OMA function in germline transcriptional repression.

Authors:  Tugba Guven-Ozkan; Scott M Robertson; Yuichi Nishi; Rueyling Lin
Journal:  Development       Date:  2010-09-08       Impact factor: 6.868

3.  N- and C-termini modulate the effects of pH and phosphorylation on hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  I J Kurland; B Chapman; M R El-Maghrabi
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

4.  Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells.

Authors:  Joshua K Salabei; Pawel K Lorkiewicz; Parul Mehra; Andrew A Gibb; Petra Haberzettl; Kyung U Hong; Xiaoli Wei; Xiang Zhang; Qianhong Li; Marcin Wysoczynski; Roberto Bolli; Aruni Bhatnagar; Bradford G Hill
Journal:  J Biol Chem       Date:  2016-05-05       Impact factor: 5.157

5.  Overexpression of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase in mouse liver lowers blood glucose by suppressing hepatic glucose production.

Authors:  C Wu; D A Okar; C B Newgard; A J Lange
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

6.  The Effect of Elevated Concentrations of Fructose 2,6-Bisphosphate on Carbon Metabolism during Deacidification in the Crassulacean Acid Metabolism Plant Kalanchöe daigremontiana.

Authors: 
Journal:  Plant Physiol       Date:  1999-11       Impact factor: 8.340

7.  Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2).

Authors:  Dudley W Lamming; Gokhan Demirkan; Joan M Boylan; Maria M Mihaylova; Tao Peng; Jonathan Ferreira; Nicola Neretti; Arthur Salomon; David M Sabatini; Philip A Gruppuso
Journal:  FASEB J       Date:  2013-09-26       Impact factor: 5.191

Review 8.  Covalent control of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: insights into autoregulation of a bifunctional enzyme.

Authors:  I J Kurland; S J Pilkis
Journal:  Protein Sci       Date:  1995-06       Impact factor: 6.725

9.  Cardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia.

Authors:  Qianwen Wang; Rajakumar V Donthi; Jianxun Wang; Alex J Lange; Lewis J Watson; Steven P Jones; Paul N Epstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

10.  Detection of antagonistic cellular regulatory functions by the gene-gene interference method in yeast.

Authors:  J Daniel
Journal:  Curr Genet       Date:  1996-01       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.